SEC Filing Analysis: CORCEPT THERAPEUTICS INC (CORT)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer at Corcept Therapeutics has filed a notice of intent to sell 5,000 shares, valued at approximately $367,350, under a pre-established 10b5-1 trading plan.
• Market Impact: The transaction is considered routine and is expected to have a negligible impact on the stock due to its small size relative to the company's market capitalization and the pre-planned nature of the sale.

Company Information

Field	Value
Company	CORCEPT THERAPEUTICS INC
Ticker Symbol	CORT
CIK	0001088856
Industry	PHARMACEUTICAL PREPARATIONS

Insider Information

Field	Value
Name	Lyon Joseph Douglas
CIK	0001817838
Title/Position	Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	144 (Notice of Proposed Sale)
Transaction Date	2025-11-03 (Approximate)
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	5,000
Price Per Share	$73.47 (Approximate)
Total Value	$367,350
Shares Owned After	Not specified
Ownership Type	Not specified

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$367,350
% of Market Cap	0.005%
Shares Transacted	5,000
% of Shares Outstanding	0.005%
Post-Transaction Ownership	Not specified
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market capitalization of $7.74 billion, this $367,350 proposed sale is financially immaterial to the company.
• Transaction Significance: The sale represents a negligible fraction (0.005%) of both the market capitalization and the total shares outstanding, falling well below any threshold for significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale is small and executed under a 10b5-1 plan, which decouples it from any new non-public information. The filing also shows a pattern of similar sales in the preceding months, indicating this is a routine, programmatic transaction for liquidity or diversification purposes.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction size is too small to materially affect trading volume.
• Sentiment Indicator: Neutral. Pre-planned sales by insiders are common and typically do not influence market sentiment.

Additional Context

Transaction Notes

• Special Circumstances: The sale is being conducted pursuant to a Rule 10b5-1 trading plan adopted on August 30, 2024. This indicates the decision to sell was made months in advance.
• Recent History: The filer has a documented history of selling similar amounts of stock in recent months, reinforcing the routine nature of this activity.